Early oral colostrum administration in preterm infants
Diana Maffei1, Mariana Brewer2, Champa Codipilly2
1Division of Neonatal-Perinatal Medicine, Cohen Children's Medical Center, Lilling Family Neonatal Research Lab, Feinstein Institutes for Medical Research, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, Hempstead, NY, USA. dmaffei@northwell.edu.
Insights
Early oral colostrum (OC) administration boosts immune components in preterm infants. Syringe delivery and higher doses enhance absorption of secretory IgA (sIgA) and lactoferrin, promoting a healthier microbiome.
Area of Science:
- Neonatal immunology
- Gastroenterology
- Microbiome research
Background:
- Oral colostrum (OC) may offer immune benefits to preterm infants.
- Prior research on OC effects is limited by concurrent enteral feeding.
Purpose of the Study:
- To measure oral colostrum absorption in preterm infants before enteral feeding.
- Quantify absorption via urinary secretory IgA (sIgA) and lactoferrin levels.
Main Methods:
- Colostrum collected from mothers of infants born at or before 32 weeks gestation or weighing ≤1500g.
- Urinary sIgA and lactoferrin measured; microflora analyzed in saliva and tracheal aspirates.
Main Results:
- Infants receiving OC via syringe showed significantly higher urinary sIgA and lactoferrin than those receiving it via swab (p<0.002).
- Urinary sIgA levels positively correlated with the cumulative dose over 72 hours (R²=43%, p<0.01).
Conclusions:
- Syringe administration and increased cumulative doses of OC enhance sIgA and lactoferrin absorption.
- Early OC dosing may promote a more diverse tracheal microbiome in preterm infants.
Background:
Early administration of colostrum may provide preterm infants with immune components. Previous studies illustrating the effects of oral colostrum (OC) have been confounded by the coincidence of enteral feedings.
Objective:
To quantify OC absorption, as measured by urinary sIgA and lactoferrin, in preterm infants prior to enteral feedings.
Materials And Methods:
Colostrum was obtained from mothers delivering infants ≤32 weeks and ≤1500 g. sIgA and lactoferrin were measured in infant urine, and microflora in saliva and tracheal aspirates were characterized.
Results:
Urinary sIgA and lactoferrin were significantly greater in infants receiving OC by syringe compared to swab (p < 0.002). Urinary sIgA correlated with the total number of doses in 72 h (R2 = 43%, p < 0.01).
Conclusions:
Administration of OC by syringe and higher cumulative dose are associated with increased absorption of sIgA and lactoferrin, and early dosing may contribute to a more diverse tracheal microbiome.
Related Concept Videos
Drug Dosing: Infants and Children
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...


